Vagal-nerve stimulation for epilepsy

Lancet

Volumn 357, Issue 9270, 2001, Pages 1726-1727

  Chadwick, David ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

CLINICAL FEATURE; CLINICAL TRIAL; COST; COUGHING; DRUG EFFECT; DRUG EFFICACY; EPILEPSY; FOLLOW UP; HEART FAILURE; HUMAN; IMPLANTATION; LARYNX DISORDER; MONKEY; MORTALITY; NERVE STIMULATION; NOTE; PAIN; PRIORITY JOURNAL; PULSE GENERATOR; RISK FACTOR; SEIZURE; STIMULUS RESPONSE; SUDDEN DEATH;

EID: 0035796009     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04933-3     Document Type: Note

References (12)

1. Inhibition of experimental seizures in canines by repetitive vagal stimulation
2. Effects of vagal stimulation on experimentally induced seizures in rats
3. Suppression of interictal spikes and seizures by stimulation of vagus nerve
4. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures
5. Vagus nerve stimulation therapy for partial-onset seizures: A randomized active-control trial
6. New drug treatment for epilepsy
7. Vagus nerve stimulation for the treatment of medically intractable seizures
8. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures
9. Ventricular asystole during vagus nerve stimulation for epilepsy in humans
10. Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death
11. Vagus nerve stimulation for intractable epilepsy in children
12. Efficacy of vagal nerve stimulation in children with medically refractory epilepsy